External Validation of the PREVENT Equations in a National Sample of US Adults
Authors:
- Sadiya S. KhanSKSadiya S. Khan
- Yingying SangYSYingying Sang
- Xiaoning HuangXHXiaoning Huang
- Lucia C. PetitoLPLucia C. Petito
- Chuan HongCHChuan Hong
- Michael J. PencinaMPMichael J. Pencina
- Shoshana H. BallewSBShoshana H. Ballew
- Morgan E. GramsMGMorgan E. Grams
- Chiadi E. NdumeleCNChiadi E. Ndumele
- Donald M. Lloyd-JonesDLDonald M. Lloyd-Jones
- Josef CoreshJCJosef Coresh
- 1 September 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Population Health and Outcomes
- Vol. 19 (9)
Abstract
BACKGROUND: The American Heart Association Predicting Risk of Cardiovascular Disease EVENT (PREVENT) equations were developed from observational research cohorts and electronic health record data and provide sex-specific risk estimates for cardiovascular disease (CVD), atherosclerotic CVD (ASCVD), and heart failure (HF). External validation in large contemporary samples across multiple health systems in the United States is needed. METHODS: We assembled a national electronic health record-based cohort of US adults with individual-level patient data pooled from a collective of 30 health systems (Truveta) to externally validate the outcome-specific 10-year PREVENT equations (PREVENT-CVD, PREVENT-ASCVD, and PREVENT-HF). We included patients aged 30 to 79 years without a history of prior CVD and with an ambulatory encounter in the electronic health record between 2013 and 2018. The outcomes were defined as total CVD (composite of ASCVD and HF), ASCVD, and HF through December 2024 using diagnosis codes. Model performance of the outcome-specific PREVENT base equations was assessed with the Harrell C statistic and calibration slope, stratified by sex. RESULTS: Of the 680 864 adults included, the mean (SD) age was 55 (13) years, and 56% were women. Over a mean (SD) follow-up of 6.8 (2.3) years, there were 29 535 incident CVD events, 19 280 incident ASCVD events, and 16 824 incident HF events. The median (interquartile range) 10-year predicted risk of PREVENT-CVD among women was 3.6% (1.3%–8.8%), and among men was 5.8% (2.5%–11.7%). The C statistic (95% CI) was 0.788 (0.786–0.790), and the calibration slope (95% CI) was 0.98 (0.95–1.01) for PREVENT-CVD. PREVENT-ASCVD and PREVENT-HF demonstrated similar C statistics (0.774 [0.771–0.777] and 0.824 [0.820–0.828]) and calibration slopes (1.07 [1.04–1.10] and 1.01 [0.97–1.04]) for prediction of the 10-year risk of ASCVD and HF, respectively. CONCLUSIONS: The PREVENT equations accurately and precisely estimate the 10-year risk of CVD, ASCVD, and HF in a large sample of US adults. These findings support the generalizability of the PREVENT equations to inform guideline-recommended risk assessment and preventive efforts.Keywords
This publication has 32 references indexed in Scilit:
- Evaluation of the PREVENT Equations in a Nationwide Cohort of 7.7 Million Korean AdultsJACC, 2025
- Performance of the American Heart Association’s PREVENT Equations Among Disaggregated Racial and Ethnic SubgroupsJAMA Cardiology, 2025
- AHA PREVENT Equations and Lipoprotein(a) for Cardiovascular Disease Risk JAMA Cardiology, 2025
- AHA PREVENT Equations and Cardiovascular Disease Risk in Diverse Health Care PopulationsJACC, 2025
- Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or ObesityJAMA Network Open, 2025
- Tailoring Risk Prediction Models to Local PopulationsJAMA Cardiology, 2024
- External Validation of the American Heart Association PREVENT Cardiovascular Disease Risk EquationsJAMA Network Open, 2024
- Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or ObesityJAMA Internal Medicine, 2024
- Time-Series Analysis of First-Time Pediatric Speech Delays From 2018 to 2022JAMA Pediatrics, 2024
- Managing Atherosclerotic Cardiovascular Risk in Young AdultsJACC, 2022